Bioactivity | Creatine kinase-MB (CK-MB), Human heart is a cardiac biomarker that can be used for early-phase risk detection of periprocedural myocardial infarction (PMI) after coronary artery bypass grafting (CABG)[1]. |
CAS | 9001-15-4 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Romeo JL, et, al. Modeling creatine-kinase MB concentrations following coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2024 Aug 21:S0022-5223(24)00703-7. |